Results 221 to 230 of about 25,002 (268)
Some of the next articles are maybe not open access.
15-Lipoxygenase inhibitors: a patent review
Expert Opinion on Therapeutic Patents, 201515-Lipoxygenases (15-LOXes) are a family of iron-containing proteins that have the capability for unsaturated fatty acid peroxidation in animals and plants. Two types of the enzyme, 15-LOX-1 and 15-LOX-2, have been recognized in mammals to have different abilities in the peroxidation of arachidonic acid and linoleic acid.
Hamid, Sadeghian, Atena, Jabbari
openaire +2 more sources
Hydroxamic acid inhibitors of 5-lipoxygenase
Journal of Medicinal Chemistry, 1987The hydroxamic acid functionality can be incorporated in a variety of simple molecules to produce potent inhibitors of 5-lipoxygenase. As an example of this, the structure-activity relationships in a series of omega-phenylalkyl and omega-naphthylalkyl hydroxamic acids are presented. Among the features described are the influence of hydrophobicity, aryl
J B, Summers +5 more
openaire +2 more sources
4-Hydroxythiazole inhibitors of 5-lipoxygenase
Journal of Medicinal Chemistry, 19914-Hydroxythiazoles have been identified as potent inhibitors of 5-lipoxygenase in vitro exhibiting IC50's of less than 1 microM. An investigation of structure-activity relationships showed that the most potent inhibitors of this series are the 5-phenyl derivatives. The corresponding thiazolidin-4-one analogues were found to be relatively inactive.
F A, Kerdesky +6 more
openaire +2 more sources
Evaluation of the antioxidative properties of lipoxygenase inhibitors
Pharmacological Reports, 2012Oxidative stress is a component of many pathological conditions including neurodegenerative diseases and inflammation. An important source of reactive oxygen species (ROS) are lipoxygenases (LOX) - enzymes responsible for the metabolism of arachidonic acid and other polyunsaturated fatty acids.
Grzegorz A, Czapski +2 more
openaire +2 more sources
Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase [PDF]
A series of 2-chloro-quinoline-based imidazopyridines 6a–l and imidazothiazoles 6m–o bearing a bulky alkylamine side chain were synthesized as soybean 15-LOX inhibitors.
Setareh Moghimi +2 more
exaly +2 more sources
Therapeutic options for 5-lipoxygenase inhibitors
Pharmacology & Therapeutics, 20065-Lipoxygenase (5-LO) catalyzes the conversion of arachidonic acid (AA) into leukotriene (LT) A(4) and 5-hydroperoxyeicosatetraenoic acid. LTA(4) can then be converted into LTB(4) by LTA(4) hydrolase or into LTC(4) by LTC(4) synthase and the LTC(4) synthase isoenzymes MGST2 and MGST3.
Oliver, Werz, Dieter, Steinhilber
openaire +2 more sources
Synthesis of new sulfonamides as lipoxygenase inhibitors
Bioorganic & Medicinal Chemistry, 2012The present study describes a convenient method for the synthesis of new lipoxygenase inhibitors, 4-(toluene-4-sulfonylamino)-benzoic acids from p-amino benzoic acid. Reaction of p-amino benzoic acid with p-toluenesulfonyl chloride provided thirteen N- and O-alkylation products 4a-4m in moderate to good yields.
Ghulam, Mustafa +5 more
openaire +2 more sources
A lipoxygenase inhibitor from Aspergillus niger
Applied Microbiology and Biotechnology, 2002A lipoxygenase-1 (LOX-1) inhibitor was isolated from the fermented broth of Aspergillus niger CFTRI 1105. It was purified, using column and preparative thin layer chromatography. 1H NMR and GC-MS examination revealed the structure of the inhibitor to be 2-(2'-methyl, 4'-hydroxyphenyl), 2-(4"hydroxyphenyl)-propane with a molecular weight of 242 and the ...
Rao K C, Sekhar +4 more
openaire +2 more sources
Conversion of cyclooxygenase inhibitors into hydroxythiazole 5-lipoxygenase inhibitors
Bioorganic & Medicinal Chemistry, 1997Representative examples of NSAID cyclooxygenase inhibitors such as naproxen, ibufenac, ibuprofen, and butibufen have been transformed into 5-lipoxygenase inhibitors by replacement of the carboxylic acid moiety with a 4-hydroxythiazole group.
F A, Kerdesky +4 more
openaire +2 more sources
Agents and Actions, 1985
Studies on the combined effects of a variety of lipoxygenase inhibitors and cyclo-oxygenase inhibitors revealed strong evidence for the existence of supplementary binding sites on lipoxygenases which modify the reactions of inhibitors with the catalytic site of the enzyme.
J, Baumann, G, Wurm, I, Baumann
openaire +2 more sources
Studies on the combined effects of a variety of lipoxygenase inhibitors and cyclo-oxygenase inhibitors revealed strong evidence for the existence of supplementary binding sites on lipoxygenases which modify the reactions of inhibitors with the catalytic site of the enzyme.
J, Baumann, G, Wurm, I, Baumann
openaire +2 more sources

